Global Oncology Radiopharmaceutical Market Growth 2026-2032
The global Oncology Radiopharmaceutical market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for Oncology Radiopharmaceutical is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Oncology Radiopharmaceutical is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Oncology Radiopharmaceutical is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Oncology Radiopharmaceutical players cover Novartis, Chimeric Therapeutics Limited, Fusion Pharma, Lantheus Medical lmaging, Inc., NanoMab, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Oncology Radiopharmaceutical Industry Forecast” looks at past sales and reviews total world Oncology Radiopharmaceutical sales in 2025, providing a comprehensive analysis by region and market sector of projected Oncology Radiopharmaceutical sales for 2026 through 2032. With Oncology Radiopharmaceutical sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oncology Radiopharmaceutical industry.
This Insight Report provides a comprehensive analysis of the global Oncology Radiopharmaceutical landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oncology Radiopharmaceutical portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oncology Radiopharmaceutical market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oncology Radiopharmaceutical and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oncology Radiopharmaceutical.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncology Radiopharmaceutical market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
United States market for Oncology Radiopharmaceutical is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Oncology Radiopharmaceutical is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Oncology Radiopharmaceutical is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Oncology Radiopharmaceutical players cover Novartis, Chimeric Therapeutics Limited, Fusion Pharma, Lantheus Medical lmaging, Inc., NanoMab, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Oncology Radiopharmaceutical Industry Forecast” looks at past sales and reviews total world Oncology Radiopharmaceutical sales in 2025, providing a comprehensive analysis by region and market sector of projected Oncology Radiopharmaceutical sales for 2026 through 2032. With Oncology Radiopharmaceutical sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oncology Radiopharmaceutical industry.
This Insight Report provides a comprehensive analysis of the global Oncology Radiopharmaceutical landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oncology Radiopharmaceutical portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oncology Radiopharmaceutical market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oncology Radiopharmaceutical and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oncology Radiopharmaceutical.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncology Radiopharmaceutical market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Oral Drugs
- Intravenous Drugs
- Other
- Hospitals and Clinics
- Pharmaceutical Company
- Research Center
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- Chimeric Therapeutics Limited
- Fusion Pharma
- Lantheus Medical lmaging, Inc.
- NanoMab
- NuView Life Sciences.
- PentixaPharm GmbHPrecirix
- RadioMedix
- RayzeBio
- Telix Pharmaceuticals Limited
- Theragnostics Ltd
- Vect-Horus
- What is the 10-year outlook for the global Oncology Radiopharmaceutical market?
- What factors are driving Oncology Radiopharmaceutical market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Oncology Radiopharmaceutical market opportunities vary by end market size?
- How does Oncology Radiopharmaceutical break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oncology Radiopharmaceutical Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Oncology Radiopharmaceutical by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Oncology Radiopharmaceutical by Country/Region, 2021, 2025 & 2032
2.2 Oncology Radiopharmaceutical Segment by Type
2.2.1 Oral Drugs
2.2.2 Intravenous Drugs
2.2.3 Other
2.2.4 Oncology Radiopharmaceutical Sales by Type
2.2.4.1 Global Oncology Radiopharmaceutical Sales Market Share by Type (2021-2026)
2.2.4.2 Global Oncology Radiopharmaceutical Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Oncology Radiopharmaceutical Sale Price by Type (2021-2026)
2.3 Oncology Radiopharmaceutical Segment by Application
2.3.1 Hospitals and Clinics
2.3.2 Pharmaceutical Company
2.3.3 Research Center
2.3.4 Other
2.3.5 Oncology Radiopharmaceutical Sales by Application
2.3.5.1 Global Oncology Radiopharmaceutical Sale Market Share by Application (2021-2026)
2.3.5.2 Global Oncology Radiopharmaceutical Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Oncology Radiopharmaceutical Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Oncology Radiopharmaceutical Breakdown Data by Company
3.1.1 Global Oncology Radiopharmaceutical Annual Sales by Company (2021-2026)
3.1.2 Global Oncology Radiopharmaceutical Sales Market Share by Company (2021-2026)
3.2 Global Oncology Radiopharmaceutical Annual Revenue by Company (2021-2026)
3.2.1 Global Oncology Radiopharmaceutical Revenue by Company (2021-2026)
3.2.2 Global Oncology Radiopharmaceutical Revenue Market Share by Company (2021-2026)
3.3 Global Oncology Radiopharmaceutical Sale Price by Company
3.4 Key Manufacturers Oncology Radiopharmaceutical Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oncology Radiopharmaceutical Product Location Distribution
3.4.2 Players Oncology Radiopharmaceutical Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ONCOLOGY RADIOPHARMACEUTICAL BY GEOGRAPHIC REGION
4.1 World Historic Oncology Radiopharmaceutical Market Size by Geographic Region (2021-2026)
4.1.1 Global Oncology Radiopharmaceutical Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Oncology Radiopharmaceutical Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Oncology Radiopharmaceutical Market Size by Country/Region (2021-2026)
4.2.1 Global Oncology Radiopharmaceutical Annual Sales by Country/Region (2021-2026)
4.2.2 Global Oncology Radiopharmaceutical Annual Revenue by Country/Region (2021-2026)
4.3 Americas Oncology Radiopharmaceutical Sales Growth
4.4 APAC Oncology Radiopharmaceutical Sales Growth
4.5 Europe Oncology Radiopharmaceutical Sales Growth
4.6 Middle East & Africa Oncology Radiopharmaceutical Sales Growth
5 AMERICAS
5.1 Americas Oncology Radiopharmaceutical Sales by Country
5.1.1 Americas Oncology Radiopharmaceutical Sales by Country (2021-2026)
5.1.2 Americas Oncology Radiopharmaceutical Revenue by Country (2021-2026)
5.2 Americas Oncology Radiopharmaceutical Sales by Type (2021-2026)
5.3 Americas Oncology Radiopharmaceutical Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncology Radiopharmaceutical Sales by Region
6.1.1 APAC Oncology Radiopharmaceutical Sales by Region (2021-2026)
6.1.2 APAC Oncology Radiopharmaceutical Revenue by Region (2021-2026)
6.2 APAC Oncology Radiopharmaceutical Sales by Type (2021-2026)
6.3 APAC Oncology Radiopharmaceutical Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oncology Radiopharmaceutical by Country
7.1.1 Europe Oncology Radiopharmaceutical Sales by Country (2021-2026)
7.1.2 Europe Oncology Radiopharmaceutical Revenue by Country (2021-2026)
7.2 Europe Oncology Radiopharmaceutical Sales by Type (2021-2026)
7.3 Europe Oncology Radiopharmaceutical Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oncology Radiopharmaceutical by Country
8.1.1 Middle East & Africa Oncology Radiopharmaceutical Sales by Country (2021-2026)
8.1.2 Middle East & Africa Oncology Radiopharmaceutical Revenue by Country (2021-2026)
8.2 Middle East & Africa Oncology Radiopharmaceutical Sales by Type (2021-2026)
8.3 Middle East & Africa Oncology Radiopharmaceutical Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oncology Radiopharmaceutical
10.3 Manufacturing Process Analysis of Oncology Radiopharmaceutical
10.4 Industry Chain Structure of Oncology Radiopharmaceutical
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oncology Radiopharmaceutical Distributors
11.3 Oncology Radiopharmaceutical Customer
12 WORLD FORECAST REVIEW FOR ONCOLOGY RADIOPHARMACEUTICAL BY GEOGRAPHIC REGION
12.1 Global Oncology Radiopharmaceutical Market Size Forecast by Region
12.1.1 Global Oncology Radiopharmaceutical Forecast by Region (2027-2032)
12.1.2 Global Oncology Radiopharmaceutical Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Oncology Radiopharmaceutical Forecast by Type (2027-2032)
12.7 Global Oncology Radiopharmaceutical Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Oncology Radiopharmaceutical Product Portfolios and Specifications
13.1.3 Novartis Oncology Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Chimeric Therapeutics Limited
13.2.1 Chimeric Therapeutics Limited Company Information
13.2.2 Chimeric Therapeutics Limited Oncology Radiopharmaceutical Product Portfolios and Specifications
13.2.3 Chimeric Therapeutics Limited Oncology Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Chimeric Therapeutics Limited Main Business Overview
13.2.5 Chimeric Therapeutics Limited Latest Developments
13.3 Fusion Pharma
13.3.1 Fusion Pharma Company Information
13.3.2 Fusion Pharma Oncology Radiopharmaceutical Product Portfolios and Specifications
13.3.3 Fusion Pharma Oncology Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Fusion Pharma Main Business Overview
13.3.5 Fusion Pharma Latest Developments
13.4 Lantheus Medical lmaging, Inc.
13.4.1 Lantheus Medical lmaging, Inc. Company Information
13.4.2 Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Product Portfolios and Specifications
13.4.3 Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Lantheus Medical lmaging, Inc. Main Business Overview
13.4.5 Lantheus Medical lmaging, Inc. Latest Developments
13.5 NanoMab
13.5.1 NanoMab Company Information
13.5.2 NanoMab Oncology Radiopharmaceutical Product Portfolios and Specifications
13.5.3 NanoMab Oncology Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 NanoMab Main Business Overview
13.5.5 NanoMab Latest Developments
13.6 NuView Life Sciences.
13.6.1 NuView Life Sciences. Company Information
13.6.2 NuView Life Sciences. Oncology Radiopharmaceutical Product Portfolios and Specifications
13.6.3 NuView Life Sciences. Oncology Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 NuView Life Sciences. Main Business Overview
13.6.5 NuView Life Sciences. Latest Developments
13.7 PentixaPharm GmbHPrecirix
13.7.1 PentixaPharm GmbHPrecirix Company Information
13.7.2 PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Product Portfolios and Specifications
13.7.3 PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 PentixaPharm GmbHPrecirix Main Business Overview
13.7.5 PentixaPharm GmbHPrecirix Latest Developments
13.8 RadioMedix
13.8.1 RadioMedix Company Information
13.8.2 RadioMedix Oncology Radiopharmaceutical Product Portfolios and Specifications
13.8.3 RadioMedix Oncology Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 RadioMedix Main Business Overview
13.8.5 RadioMedix Latest Developments
13.9 RayzeBio
13.9.1 RayzeBio Company Information
13.9.2 RayzeBio Oncology Radiopharmaceutical Product Portfolios and Specifications
13.9.3 RayzeBio Oncology Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 RayzeBio Main Business Overview
13.9.5 RayzeBio Latest Developments
13.10 Telix Pharmaceuticals Limited
13.10.1 Telix Pharmaceuticals Limited Company Information
13.10.2 Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Product Portfolios and Specifications
13.10.3 Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Telix Pharmaceuticals Limited Main Business Overview
13.10.5 Telix Pharmaceuticals Limited Latest Developments
13.11 Theragnostics Ltd
13.11.1 Theragnostics Ltd Company Information
13.11.2 Theragnostics Ltd Oncology Radiopharmaceutical Product Portfolios and Specifications
13.11.3 Theragnostics Ltd Oncology Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Theragnostics Ltd Main Business Overview
13.11.5 Theragnostics Ltd Latest Developments
13.12 Vect-Horus
13.12.1 Vect-Horus Company Information
13.12.2 Vect-Horus Oncology Radiopharmaceutical Product Portfolios and Specifications
13.12.3 Vect-Horus Oncology Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Vect-Horus Main Business Overview
13.12.5 Vect-Horus Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oncology Radiopharmaceutical Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Oncology Radiopharmaceutical by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Oncology Radiopharmaceutical by Country/Region, 2021, 2025 & 2032
2.2 Oncology Radiopharmaceutical Segment by Type
2.2.1 Oral Drugs
2.2.2 Intravenous Drugs
2.2.3 Other
2.2.4 Oncology Radiopharmaceutical Sales by Type
2.2.4.1 Global Oncology Radiopharmaceutical Sales Market Share by Type (2021-2026)
2.2.4.2 Global Oncology Radiopharmaceutical Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Oncology Radiopharmaceutical Sale Price by Type (2021-2026)
2.3 Oncology Radiopharmaceutical Segment by Application
2.3.1 Hospitals and Clinics
2.3.2 Pharmaceutical Company
2.3.3 Research Center
2.3.4 Other
2.3.5 Oncology Radiopharmaceutical Sales by Application
2.3.5.1 Global Oncology Radiopharmaceutical Sale Market Share by Application (2021-2026)
2.3.5.2 Global Oncology Radiopharmaceutical Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Oncology Radiopharmaceutical Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Oncology Radiopharmaceutical Breakdown Data by Company
3.1.1 Global Oncology Radiopharmaceutical Annual Sales by Company (2021-2026)
3.1.2 Global Oncology Radiopharmaceutical Sales Market Share by Company (2021-2026)
3.2 Global Oncology Radiopharmaceutical Annual Revenue by Company (2021-2026)
3.2.1 Global Oncology Radiopharmaceutical Revenue by Company (2021-2026)
3.2.2 Global Oncology Radiopharmaceutical Revenue Market Share by Company (2021-2026)
3.3 Global Oncology Radiopharmaceutical Sale Price by Company
3.4 Key Manufacturers Oncology Radiopharmaceutical Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oncology Radiopharmaceutical Product Location Distribution
3.4.2 Players Oncology Radiopharmaceutical Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ONCOLOGY RADIOPHARMACEUTICAL BY GEOGRAPHIC REGION
4.1 World Historic Oncology Radiopharmaceutical Market Size by Geographic Region (2021-2026)
4.1.1 Global Oncology Radiopharmaceutical Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Oncology Radiopharmaceutical Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Oncology Radiopharmaceutical Market Size by Country/Region (2021-2026)
4.2.1 Global Oncology Radiopharmaceutical Annual Sales by Country/Region (2021-2026)
4.2.2 Global Oncology Radiopharmaceutical Annual Revenue by Country/Region (2021-2026)
4.3 Americas Oncology Radiopharmaceutical Sales Growth
4.4 APAC Oncology Radiopharmaceutical Sales Growth
4.5 Europe Oncology Radiopharmaceutical Sales Growth
4.6 Middle East & Africa Oncology Radiopharmaceutical Sales Growth
5 AMERICAS
5.1 Americas Oncology Radiopharmaceutical Sales by Country
5.1.1 Americas Oncology Radiopharmaceutical Sales by Country (2021-2026)
5.1.2 Americas Oncology Radiopharmaceutical Revenue by Country (2021-2026)
5.2 Americas Oncology Radiopharmaceutical Sales by Type (2021-2026)
5.3 Americas Oncology Radiopharmaceutical Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncology Radiopharmaceutical Sales by Region
6.1.1 APAC Oncology Radiopharmaceutical Sales by Region (2021-2026)
6.1.2 APAC Oncology Radiopharmaceutical Revenue by Region (2021-2026)
6.2 APAC Oncology Radiopharmaceutical Sales by Type (2021-2026)
6.3 APAC Oncology Radiopharmaceutical Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oncology Radiopharmaceutical by Country
7.1.1 Europe Oncology Radiopharmaceutical Sales by Country (2021-2026)
7.1.2 Europe Oncology Radiopharmaceutical Revenue by Country (2021-2026)
7.2 Europe Oncology Radiopharmaceutical Sales by Type (2021-2026)
7.3 Europe Oncology Radiopharmaceutical Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oncology Radiopharmaceutical by Country
8.1.1 Middle East & Africa Oncology Radiopharmaceutical Sales by Country (2021-2026)
8.1.2 Middle East & Africa Oncology Radiopharmaceutical Revenue by Country (2021-2026)
8.2 Middle East & Africa Oncology Radiopharmaceutical Sales by Type (2021-2026)
8.3 Middle East & Africa Oncology Radiopharmaceutical Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oncology Radiopharmaceutical
10.3 Manufacturing Process Analysis of Oncology Radiopharmaceutical
10.4 Industry Chain Structure of Oncology Radiopharmaceutical
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oncology Radiopharmaceutical Distributors
11.3 Oncology Radiopharmaceutical Customer
12 WORLD FORECAST REVIEW FOR ONCOLOGY RADIOPHARMACEUTICAL BY GEOGRAPHIC REGION
12.1 Global Oncology Radiopharmaceutical Market Size Forecast by Region
12.1.1 Global Oncology Radiopharmaceutical Forecast by Region (2027-2032)
12.1.2 Global Oncology Radiopharmaceutical Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Oncology Radiopharmaceutical Forecast by Type (2027-2032)
12.7 Global Oncology Radiopharmaceutical Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Oncology Radiopharmaceutical Product Portfolios and Specifications
13.1.3 Novartis Oncology Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Chimeric Therapeutics Limited
13.2.1 Chimeric Therapeutics Limited Company Information
13.2.2 Chimeric Therapeutics Limited Oncology Radiopharmaceutical Product Portfolios and Specifications
13.2.3 Chimeric Therapeutics Limited Oncology Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Chimeric Therapeutics Limited Main Business Overview
13.2.5 Chimeric Therapeutics Limited Latest Developments
13.3 Fusion Pharma
13.3.1 Fusion Pharma Company Information
13.3.2 Fusion Pharma Oncology Radiopharmaceutical Product Portfolios and Specifications
13.3.3 Fusion Pharma Oncology Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Fusion Pharma Main Business Overview
13.3.5 Fusion Pharma Latest Developments
13.4 Lantheus Medical lmaging, Inc.
13.4.1 Lantheus Medical lmaging, Inc. Company Information
13.4.2 Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Product Portfolios and Specifications
13.4.3 Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Lantheus Medical lmaging, Inc. Main Business Overview
13.4.5 Lantheus Medical lmaging, Inc. Latest Developments
13.5 NanoMab
13.5.1 NanoMab Company Information
13.5.2 NanoMab Oncology Radiopharmaceutical Product Portfolios and Specifications
13.5.3 NanoMab Oncology Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 NanoMab Main Business Overview
13.5.5 NanoMab Latest Developments
13.6 NuView Life Sciences.
13.6.1 NuView Life Sciences. Company Information
13.6.2 NuView Life Sciences. Oncology Radiopharmaceutical Product Portfolios and Specifications
13.6.3 NuView Life Sciences. Oncology Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 NuView Life Sciences. Main Business Overview
13.6.5 NuView Life Sciences. Latest Developments
13.7 PentixaPharm GmbHPrecirix
13.7.1 PentixaPharm GmbHPrecirix Company Information
13.7.2 PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Product Portfolios and Specifications
13.7.3 PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 PentixaPharm GmbHPrecirix Main Business Overview
13.7.5 PentixaPharm GmbHPrecirix Latest Developments
13.8 RadioMedix
13.8.1 RadioMedix Company Information
13.8.2 RadioMedix Oncology Radiopharmaceutical Product Portfolios and Specifications
13.8.3 RadioMedix Oncology Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 RadioMedix Main Business Overview
13.8.5 RadioMedix Latest Developments
13.9 RayzeBio
13.9.1 RayzeBio Company Information
13.9.2 RayzeBio Oncology Radiopharmaceutical Product Portfolios and Specifications
13.9.3 RayzeBio Oncology Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 RayzeBio Main Business Overview
13.9.5 RayzeBio Latest Developments
13.10 Telix Pharmaceuticals Limited
13.10.1 Telix Pharmaceuticals Limited Company Information
13.10.2 Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Product Portfolios and Specifications
13.10.3 Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Telix Pharmaceuticals Limited Main Business Overview
13.10.5 Telix Pharmaceuticals Limited Latest Developments
13.11 Theragnostics Ltd
13.11.1 Theragnostics Ltd Company Information
13.11.2 Theragnostics Ltd Oncology Radiopharmaceutical Product Portfolios and Specifications
13.11.3 Theragnostics Ltd Oncology Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Theragnostics Ltd Main Business Overview
13.11.5 Theragnostics Ltd Latest Developments
13.12 Vect-Horus
13.12.1 Vect-Horus Company Information
13.12.2 Vect-Horus Oncology Radiopharmaceutical Product Portfolios and Specifications
13.12.3 Vect-Horus Oncology Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Vect-Horus Main Business Overview
13.12.5 Vect-Horus Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Oncology Radiopharmaceutical Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Oncology Radiopharmaceutical Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Oral Drugs
Table 4. Major Players of Intravenous Drugs
Table 5. Major Players of Other
Table 6. Global Oncology Radiopharmaceutical Sales by Type (2021-2026) & (K Units)
Table 7. Global Oncology Radiopharmaceutical Sales Market Share by Type (2021-2026)
Table 8. Global Oncology Radiopharmaceutical Revenue by Type (2021-2026) & ($ million)
Table 9. Global Oncology Radiopharmaceutical Revenue Market Share by Type (2021-2026)
Table 10. Global Oncology Radiopharmaceutical Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Oncology Radiopharmaceutical Sale by Application (2021-2026) & (K Units)
Table 12. Global Oncology Radiopharmaceutical Sale Market Share by Application (2021-2026)
Table 13. Global Oncology Radiopharmaceutical Revenue by Application (2021-2026) & ($ million)
Table 14. Global Oncology Radiopharmaceutical Revenue Market Share by Application (2021-2026)
Table 15. Global Oncology Radiopharmaceutical Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Oncology Radiopharmaceutical Sales by Company (2021-2026) & (K Units)
Table 17. Global Oncology Radiopharmaceutical Sales Market Share by Company (2021-2026)
Table 18. Global Oncology Radiopharmaceutical Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Oncology Radiopharmaceutical Revenue Market Share by Company (2021-2026)
Table 20. Global Oncology Radiopharmaceutical Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Oncology Radiopharmaceutical Producing Area Distribution and Sales Area
Table 22. Players Oncology Radiopharmaceutical Products Offered
Table 23. Oncology Radiopharmaceutical Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Oncology Radiopharmaceutical Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Oncology Radiopharmaceutical Sales Market Share Geographic Region (2021-2026)
Table 28. Global Oncology Radiopharmaceutical Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Oncology Radiopharmaceutical Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Oncology Radiopharmaceutical Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Oncology Radiopharmaceutical Sales Market Share by Country/Region (2021-2026)
Table 32. Global Oncology Radiopharmaceutical Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Oncology Radiopharmaceutical Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Oncology Radiopharmaceutical Sales by Country (2021-2026) & (K Units)
Table 35. Americas Oncology Radiopharmaceutical Sales Market Share by Country (2021-2026)
Table 36. Americas Oncology Radiopharmaceutical Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Oncology Radiopharmaceutical Sales by Type (2021-2026) & (K Units)
Table 38. Americas Oncology Radiopharmaceutical Sales by Application (2021-2026) & (K Units)
Table 39. APAC Oncology Radiopharmaceutical Sales by Region (2021-2026) & (K Units)
Table 40. APAC Oncology Radiopharmaceutical Sales Market Share by Region (2021-2026)
Table 41. APAC Oncology Radiopharmaceutical Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Oncology Radiopharmaceutical Sales by Type (2021-2026) & (K Units)
Table 43. APAC Oncology Radiopharmaceutical Sales by Application (2021-2026) & (K Units)
Table 44. Europe Oncology Radiopharmaceutical Sales by Country (2021-2026) & (K Units)
Table 45. Europe Oncology Radiopharmaceutical Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Oncology Radiopharmaceutical Sales by Type (2021-2026) & (K Units)
Table 47. Europe Oncology Radiopharmaceutical Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Oncology Radiopharmaceutical Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Oncology Radiopharmaceutical Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Oncology Radiopharmaceutical Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Oncology Radiopharmaceutical Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Oncology Radiopharmaceutical
Table 53. Key Market Challenges & Risks of Oncology Radiopharmaceutical
Table 54. Key Industry Trends of Oncology Radiopharmaceutical
Table 55. Oncology Radiopharmaceutical Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Oncology Radiopharmaceutical Distributors List
Table 58. Oncology Radiopharmaceutical Customer List
Table 59. Global Oncology Radiopharmaceutical Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Oncology Radiopharmaceutical Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Oncology Radiopharmaceutical Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Oncology Radiopharmaceutical Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Oncology Radiopharmaceutical Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Oncology Radiopharmaceutical Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Oncology Radiopharmaceutical Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Oncology Radiopharmaceutical Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Oncology Radiopharmaceutical Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Oncology Radiopharmaceutical Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Oncology Radiopharmaceutical Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Oncology Radiopharmaceutical Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Oncology Radiopharmaceutical Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Oncology Radiopharmaceutical Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Novartis Basic Information, Oncology Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 74. Novartis Oncology Radiopharmaceutical Product Portfolios and Specifications
Table 75. Novartis Oncology Radiopharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Novartis Main Business
Table 77. Novartis Latest Developments
Table 78. Chimeric Therapeutics Limited Basic Information, Oncology Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 79. Chimeric Therapeutics Limited Oncology Radiopharmaceutical Product Portfolios and Specifications
Table 80. Chimeric Therapeutics Limited Oncology Radiopharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Chimeric Therapeutics Limited Main Business
Table 82. Chimeric Therapeutics Limited Latest Developments
Table 83. Fusion Pharma Basic Information, Oncology Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 84. Fusion Pharma Oncology Radiopharmaceutical Product Portfolios and Specifications
Table 85. Fusion Pharma Oncology Radiopharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Fusion Pharma Main Business
Table 87. Fusion Pharma Latest Developments
Table 88. Lantheus Medical lmaging, Inc. Basic Information, Oncology Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 89. Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Product Portfolios and Specifications
Table 90. Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Lantheus Medical lmaging, Inc. Main Business
Table 92. Lantheus Medical lmaging, Inc. Latest Developments
Table 93. NanoMab Basic Information, Oncology Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 94. NanoMab Oncology Radiopharmaceutical Product Portfolios and Specifications
Table 95. NanoMab Oncology Radiopharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. NanoMab Main Business
Table 97. NanoMab Latest Developments
Table 98. NuView Life Sciences. Basic Information, Oncology Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 99. NuView Life Sciences. Oncology Radiopharmaceutical Product Portfolios and Specifications
Table 100. NuView Life Sciences. Oncology Radiopharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. NuView Life Sciences. Main Business
Table 102. NuView Life Sciences. Latest Developments
Table 103. PentixaPharm GmbHPrecirix Basic Information, Oncology Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 104. PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Product Portfolios and Specifications
Table 105. PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. PentixaPharm GmbHPrecirix Main Business
Table 107. PentixaPharm GmbHPrecirix Latest Developments
Table 108. RadioMedix Basic Information, Oncology Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 109. RadioMedix Oncology Radiopharmaceutical Product Portfolios and Specifications
Table 110. RadioMedix Oncology Radiopharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. RadioMedix Main Business
Table 112. RadioMedix Latest Developments
Table 113. RayzeBio Basic Information, Oncology Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 114. RayzeBio Oncology Radiopharmaceutical Product Portfolios and Specifications
Table 115. RayzeBio Oncology Radiopharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. RayzeBio Main Business
Table 117. RayzeBio Latest Developments
Table 118. Telix Pharmaceuticals Limited Basic Information, Oncology Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 119. Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Product Portfolios and Specifications
Table 120. Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Telix Pharmaceuticals Limited Main Business
Table 122. Telix Pharmaceuticals Limited Latest Developments
Table 123. Theragnostics Ltd Basic Information, Oncology Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 124. Theragnostics Ltd Oncology Radiopharmaceutical Product Portfolios and Specifications
Table 125. Theragnostics Ltd Oncology Radiopharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Theragnostics Ltd Main Business
Table 127. Theragnostics Ltd Latest Developments
Table 128. Vect-Horus Basic Information, Oncology Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 129. Vect-Horus Oncology Radiopharmaceutical Product Portfolios and Specifications
Table 130. Vect-Horus Oncology Radiopharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Vect-Horus Main Business
Table 132. Vect-Horus Latest Developments
Table 1. Oncology Radiopharmaceutical Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Oncology Radiopharmaceutical Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Oral Drugs
Table 4. Major Players of Intravenous Drugs
Table 5. Major Players of Other
Table 6. Global Oncology Radiopharmaceutical Sales by Type (2021-2026) & (K Units)
Table 7. Global Oncology Radiopharmaceutical Sales Market Share by Type (2021-2026)
Table 8. Global Oncology Radiopharmaceutical Revenue by Type (2021-2026) & ($ million)
Table 9. Global Oncology Radiopharmaceutical Revenue Market Share by Type (2021-2026)
Table 10. Global Oncology Radiopharmaceutical Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Oncology Radiopharmaceutical Sale by Application (2021-2026) & (K Units)
Table 12. Global Oncology Radiopharmaceutical Sale Market Share by Application (2021-2026)
Table 13. Global Oncology Radiopharmaceutical Revenue by Application (2021-2026) & ($ million)
Table 14. Global Oncology Radiopharmaceutical Revenue Market Share by Application (2021-2026)
Table 15. Global Oncology Radiopharmaceutical Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Oncology Radiopharmaceutical Sales by Company (2021-2026) & (K Units)
Table 17. Global Oncology Radiopharmaceutical Sales Market Share by Company (2021-2026)
Table 18. Global Oncology Radiopharmaceutical Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Oncology Radiopharmaceutical Revenue Market Share by Company (2021-2026)
Table 20. Global Oncology Radiopharmaceutical Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Oncology Radiopharmaceutical Producing Area Distribution and Sales Area
Table 22. Players Oncology Radiopharmaceutical Products Offered
Table 23. Oncology Radiopharmaceutical Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Oncology Radiopharmaceutical Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Oncology Radiopharmaceutical Sales Market Share Geographic Region (2021-2026)
Table 28. Global Oncology Radiopharmaceutical Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Oncology Radiopharmaceutical Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Oncology Radiopharmaceutical Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Oncology Radiopharmaceutical Sales Market Share by Country/Region (2021-2026)
Table 32. Global Oncology Radiopharmaceutical Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Oncology Radiopharmaceutical Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Oncology Radiopharmaceutical Sales by Country (2021-2026) & (K Units)
Table 35. Americas Oncology Radiopharmaceutical Sales Market Share by Country (2021-2026)
Table 36. Americas Oncology Radiopharmaceutical Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Oncology Radiopharmaceutical Sales by Type (2021-2026) & (K Units)
Table 38. Americas Oncology Radiopharmaceutical Sales by Application (2021-2026) & (K Units)
Table 39. APAC Oncology Radiopharmaceutical Sales by Region (2021-2026) & (K Units)
Table 40. APAC Oncology Radiopharmaceutical Sales Market Share by Region (2021-2026)
Table 41. APAC Oncology Radiopharmaceutical Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Oncology Radiopharmaceutical Sales by Type (2021-2026) & (K Units)
Table 43. APAC Oncology Radiopharmaceutical Sales by Application (2021-2026) & (K Units)
Table 44. Europe Oncology Radiopharmaceutical Sales by Country (2021-2026) & (K Units)
Table 45. Europe Oncology Radiopharmaceutical Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Oncology Radiopharmaceutical Sales by Type (2021-2026) & (K Units)
Table 47. Europe Oncology Radiopharmaceutical Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Oncology Radiopharmaceutical Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Oncology Radiopharmaceutical Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Oncology Radiopharmaceutical Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Oncology Radiopharmaceutical Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Oncology Radiopharmaceutical
Table 53. Key Market Challenges & Risks of Oncology Radiopharmaceutical
Table 54. Key Industry Trends of Oncology Radiopharmaceutical
Table 55. Oncology Radiopharmaceutical Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Oncology Radiopharmaceutical Distributors List
Table 58. Oncology Radiopharmaceutical Customer List
Table 59. Global Oncology Radiopharmaceutical Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Oncology Radiopharmaceutical Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Oncology Radiopharmaceutical Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Oncology Radiopharmaceutical Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Oncology Radiopharmaceutical Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Oncology Radiopharmaceutical Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Oncology Radiopharmaceutical Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Oncology Radiopharmaceutical Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Oncology Radiopharmaceutical Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Oncology Radiopharmaceutical Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Oncology Radiopharmaceutical Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Oncology Radiopharmaceutical Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Oncology Radiopharmaceutical Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Oncology Radiopharmaceutical Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Novartis Basic Information, Oncology Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 74. Novartis Oncology Radiopharmaceutical Product Portfolios and Specifications
Table 75. Novartis Oncology Radiopharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Novartis Main Business
Table 77. Novartis Latest Developments
Table 78. Chimeric Therapeutics Limited Basic Information, Oncology Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 79. Chimeric Therapeutics Limited Oncology Radiopharmaceutical Product Portfolios and Specifications
Table 80. Chimeric Therapeutics Limited Oncology Radiopharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Chimeric Therapeutics Limited Main Business
Table 82. Chimeric Therapeutics Limited Latest Developments
Table 83. Fusion Pharma Basic Information, Oncology Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 84. Fusion Pharma Oncology Radiopharmaceutical Product Portfolios and Specifications
Table 85. Fusion Pharma Oncology Radiopharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Fusion Pharma Main Business
Table 87. Fusion Pharma Latest Developments
Table 88. Lantheus Medical lmaging, Inc. Basic Information, Oncology Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 89. Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Product Portfolios and Specifications
Table 90. Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Lantheus Medical lmaging, Inc. Main Business
Table 92. Lantheus Medical lmaging, Inc. Latest Developments
Table 93. NanoMab Basic Information, Oncology Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 94. NanoMab Oncology Radiopharmaceutical Product Portfolios and Specifications
Table 95. NanoMab Oncology Radiopharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. NanoMab Main Business
Table 97. NanoMab Latest Developments
Table 98. NuView Life Sciences. Basic Information, Oncology Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 99. NuView Life Sciences. Oncology Radiopharmaceutical Product Portfolios and Specifications
Table 100. NuView Life Sciences. Oncology Radiopharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. NuView Life Sciences. Main Business
Table 102. NuView Life Sciences. Latest Developments
Table 103. PentixaPharm GmbHPrecirix Basic Information, Oncology Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 104. PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Product Portfolios and Specifications
Table 105. PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. PentixaPharm GmbHPrecirix Main Business
Table 107. PentixaPharm GmbHPrecirix Latest Developments
Table 108. RadioMedix Basic Information, Oncology Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 109. RadioMedix Oncology Radiopharmaceutical Product Portfolios and Specifications
Table 110. RadioMedix Oncology Radiopharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. RadioMedix Main Business
Table 112. RadioMedix Latest Developments
Table 113. RayzeBio Basic Information, Oncology Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 114. RayzeBio Oncology Radiopharmaceutical Product Portfolios and Specifications
Table 115. RayzeBio Oncology Radiopharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. RayzeBio Main Business
Table 117. RayzeBio Latest Developments
Table 118. Telix Pharmaceuticals Limited Basic Information, Oncology Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 119. Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Product Portfolios and Specifications
Table 120. Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Telix Pharmaceuticals Limited Main Business
Table 122. Telix Pharmaceuticals Limited Latest Developments
Table 123. Theragnostics Ltd Basic Information, Oncology Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 124. Theragnostics Ltd Oncology Radiopharmaceutical Product Portfolios and Specifications
Table 125. Theragnostics Ltd Oncology Radiopharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Theragnostics Ltd Main Business
Table 127. Theragnostics Ltd Latest Developments
Table 128. Vect-Horus Basic Information, Oncology Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 129. Vect-Horus Oncology Radiopharmaceutical Product Portfolios and Specifications
Table 130. Vect-Horus Oncology Radiopharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Vect-Horus Main Business
Table 132. Vect-Horus Latest Developments
LIST OF FIGURES
Figure 1. Picture of Oncology Radiopharmaceutical
Figure 2. Oncology Radiopharmaceutical Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oncology Radiopharmaceutical Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Oncology Radiopharmaceutical Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Oncology Radiopharmaceutical Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Oncology Radiopharmaceutical Sales Market Share by Country/Region (2025)
Figure 10. Oncology Radiopharmaceutical Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Oral Drugs
Figure 12. Product Picture of Intravenous Drugs
Figure 13. Product Picture of Other
Figure 14. Global Oncology Radiopharmaceutical Sales Market Share by Type in 2026
Figure 15. Global Oncology Radiopharmaceutical Revenue Market Share by Type (2021-2026)
Figure 16. Oncology Radiopharmaceutical Consumed in Hospitals and Clinics
Figure 17. Global Oncology Radiopharmaceutical Market: Hospitals and Clinics (2021-2026) & (K Units)
Figure 18. Oncology Radiopharmaceutical Consumed in Pharmaceutical Company
Figure 19. Global Oncology Radiopharmaceutical Market: Pharmaceutical Company (2021-2026) & (K Units)
Figure 20. Oncology Radiopharmaceutical Consumed in Research Center
Figure 21. Global Oncology Radiopharmaceutical Market: Research Center (2021-2026) & (K Units)
Figure 22. Oncology Radiopharmaceutical Consumed in Other
Figure 23. Global Oncology Radiopharmaceutical Market: Other (2021-2026) & (K Units)
Figure 24. Global Oncology Radiopharmaceutical Sale Market Share by Application (2025)
Figure 25. Global Oncology Radiopharmaceutical Revenue Market Share by Application in 2026
Figure 26. Oncology Radiopharmaceutical Sales by Company in 2026 (K Units)
Figure 27. Global Oncology Radiopharmaceutical Sales Market Share by Company in 2026
Figure 28. Oncology Radiopharmaceutical Revenue by Company in 2026 ($ millions)
Figure 29. Global Oncology Radiopharmaceutical Revenue Market Share by Company in 2026
Figure 30. Global Oncology Radiopharmaceutical Sales Market Share by Geographic Region (2021-2026)
Figure 31. Global Oncology Radiopharmaceutical Revenue Market Share by Geographic Region in 2026
Figure 32. Americas Oncology Radiopharmaceutical Sales 2021-2026 (K Units)
Figure 33. Americas Oncology Radiopharmaceutical Revenue 2021-2026 ($ millions)
Figure 34. APAC Oncology Radiopharmaceutical Sales 2021-2026 (K Units)
Figure 35. APAC Oncology Radiopharmaceutical Revenue 2021-2026 ($ millions)
Figure 36. Europe Oncology Radiopharmaceutical Sales 2021-2026 (K Units)
Figure 37. Europe Oncology Radiopharmaceutical Revenue 2021-2026 ($ millions)
Figure 38. Middle East & Africa Oncology Radiopharmaceutical Sales 2021-2026 (K Units)
Figure 39. Middle East & Africa Oncology Radiopharmaceutical Revenue 2021-2026 ($ millions)
Figure 40. Americas Oncology Radiopharmaceutical Sales Market Share by Country in 2026
Figure 41. Americas Oncology Radiopharmaceutical Revenue Market Share by Country (2021-2026)
Figure 42. Americas Oncology Radiopharmaceutical Sales Market Share by Type (2021-2026)
Figure 43. Americas Oncology Radiopharmaceutical Sales Market Share by Application (2021-2026)
Figure 44. United States Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 45. Canada Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 46. Mexico Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 47. Brazil Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 48. APAC Oncology Radiopharmaceutical Sales Market Share by Region in 2026
Figure 49. APAC Oncology Radiopharmaceutical Revenue Market Share by Region (2021-2026)
Figure 50. APAC Oncology Radiopharmaceutical Sales Market Share by Type (2021-2026)
Figure 51. APAC Oncology Radiopharmaceutical Sales Market Share by Application (2021-2026)
Figure 52. China Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 53. Japan Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 54. South Korea Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 55. Southeast Asia Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 56. India Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 57. Australia Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 58. China Taiwan Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 59. Europe Oncology Radiopharmaceutical Sales Market Share by Country in 2026
Figure 60. Europe Oncology Radiopharmaceutical Revenue Market Share by Country (2021-2026)
Figure 61. Europe Oncology Radiopharmaceutical Sales Market Share by Type (2021-2026)
Figure 62. Europe Oncology Radiopharmaceutical Sales Market Share by Application (2021-2026)
Figure 63. Germany Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 64. France Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 65. UK Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 66. Italy Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 67. Russia Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 68. Middle East & Africa Oncology Radiopharmaceutical Sales Market Share by Country (2021-2026)
Figure 69. Middle East & Africa Oncology Radiopharmaceutical Sales Market Share by Type (2021-2026)
Figure 70. Middle East & Africa Oncology Radiopharmaceutical Sales Market Share by Application (2021-2026)
Figure 71. Egypt Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 72. South Africa Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 73. Israel Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 74. Turkey Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 75. GCC Countries Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Oncology Radiopharmaceutical in 2026
Figure 77. Manufacturing Process Analysis of Oncology Radiopharmaceutical
Figure 78. Industry Chain Structure of Oncology Radiopharmaceutical
Figure 79. Channels of Distribution
Figure 80. Global Oncology Radiopharmaceutical Sales Market Forecast by Region (2027-2032)
Figure 81. Global Oncology Radiopharmaceutical Revenue Market Share Forecast by Region (2027-2032)
Figure 82. Global Oncology Radiopharmaceutical Sales Market Share Forecast by Type (2027-2032)
Figure 83. Global Oncology Radiopharmaceutical Revenue Market Share Forecast by Type (2027-2032)
Figure 84. Global Oncology Radiopharmaceutical Sales Market Share Forecast by Application (2027-2032)
Figure 85. Global Oncology Radiopharmaceutical Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Oncology Radiopharmaceutical
Figure 2. Oncology Radiopharmaceutical Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oncology Radiopharmaceutical Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Oncology Radiopharmaceutical Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Oncology Radiopharmaceutical Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Oncology Radiopharmaceutical Sales Market Share by Country/Region (2025)
Figure 10. Oncology Radiopharmaceutical Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Oral Drugs
Figure 12. Product Picture of Intravenous Drugs
Figure 13. Product Picture of Other
Figure 14. Global Oncology Radiopharmaceutical Sales Market Share by Type in 2026
Figure 15. Global Oncology Radiopharmaceutical Revenue Market Share by Type (2021-2026)
Figure 16. Oncology Radiopharmaceutical Consumed in Hospitals and Clinics
Figure 17. Global Oncology Radiopharmaceutical Market: Hospitals and Clinics (2021-2026) & (K Units)
Figure 18. Oncology Radiopharmaceutical Consumed in Pharmaceutical Company
Figure 19. Global Oncology Radiopharmaceutical Market: Pharmaceutical Company (2021-2026) & (K Units)
Figure 20. Oncology Radiopharmaceutical Consumed in Research Center
Figure 21. Global Oncology Radiopharmaceutical Market: Research Center (2021-2026) & (K Units)
Figure 22. Oncology Radiopharmaceutical Consumed in Other
Figure 23. Global Oncology Radiopharmaceutical Market: Other (2021-2026) & (K Units)
Figure 24. Global Oncology Radiopharmaceutical Sale Market Share by Application (2025)
Figure 25. Global Oncology Radiopharmaceutical Revenue Market Share by Application in 2026
Figure 26. Oncology Radiopharmaceutical Sales by Company in 2026 (K Units)
Figure 27. Global Oncology Radiopharmaceutical Sales Market Share by Company in 2026
Figure 28. Oncology Radiopharmaceutical Revenue by Company in 2026 ($ millions)
Figure 29. Global Oncology Radiopharmaceutical Revenue Market Share by Company in 2026
Figure 30. Global Oncology Radiopharmaceutical Sales Market Share by Geographic Region (2021-2026)
Figure 31. Global Oncology Radiopharmaceutical Revenue Market Share by Geographic Region in 2026
Figure 32. Americas Oncology Radiopharmaceutical Sales 2021-2026 (K Units)
Figure 33. Americas Oncology Radiopharmaceutical Revenue 2021-2026 ($ millions)
Figure 34. APAC Oncology Radiopharmaceutical Sales 2021-2026 (K Units)
Figure 35. APAC Oncology Radiopharmaceutical Revenue 2021-2026 ($ millions)
Figure 36. Europe Oncology Radiopharmaceutical Sales 2021-2026 (K Units)
Figure 37. Europe Oncology Radiopharmaceutical Revenue 2021-2026 ($ millions)
Figure 38. Middle East & Africa Oncology Radiopharmaceutical Sales 2021-2026 (K Units)
Figure 39. Middle East & Africa Oncology Radiopharmaceutical Revenue 2021-2026 ($ millions)
Figure 40. Americas Oncology Radiopharmaceutical Sales Market Share by Country in 2026
Figure 41. Americas Oncology Radiopharmaceutical Revenue Market Share by Country (2021-2026)
Figure 42. Americas Oncology Radiopharmaceutical Sales Market Share by Type (2021-2026)
Figure 43. Americas Oncology Radiopharmaceutical Sales Market Share by Application (2021-2026)
Figure 44. United States Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 45. Canada Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 46. Mexico Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 47. Brazil Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 48. APAC Oncology Radiopharmaceutical Sales Market Share by Region in 2026
Figure 49. APAC Oncology Radiopharmaceutical Revenue Market Share by Region (2021-2026)
Figure 50. APAC Oncology Radiopharmaceutical Sales Market Share by Type (2021-2026)
Figure 51. APAC Oncology Radiopharmaceutical Sales Market Share by Application (2021-2026)
Figure 52. China Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 53. Japan Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 54. South Korea Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 55. Southeast Asia Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 56. India Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 57. Australia Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 58. China Taiwan Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 59. Europe Oncology Radiopharmaceutical Sales Market Share by Country in 2026
Figure 60. Europe Oncology Radiopharmaceutical Revenue Market Share by Country (2021-2026)
Figure 61. Europe Oncology Radiopharmaceutical Sales Market Share by Type (2021-2026)
Figure 62. Europe Oncology Radiopharmaceutical Sales Market Share by Application (2021-2026)
Figure 63. Germany Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 64. France Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 65. UK Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 66. Italy Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 67. Russia Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 68. Middle East & Africa Oncology Radiopharmaceutical Sales Market Share by Country (2021-2026)
Figure 69. Middle East & Africa Oncology Radiopharmaceutical Sales Market Share by Type (2021-2026)
Figure 70. Middle East & Africa Oncology Radiopharmaceutical Sales Market Share by Application (2021-2026)
Figure 71. Egypt Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 72. South Africa Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 73. Israel Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 74. Turkey Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 75. GCC Countries Oncology Radiopharmaceutical Revenue Growth 2021-2026 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Oncology Radiopharmaceutical in 2026
Figure 77. Manufacturing Process Analysis of Oncology Radiopharmaceutical
Figure 78. Industry Chain Structure of Oncology Radiopharmaceutical
Figure 79. Channels of Distribution
Figure 80. Global Oncology Radiopharmaceutical Sales Market Forecast by Region (2027-2032)
Figure 81. Global Oncology Radiopharmaceutical Revenue Market Share Forecast by Region (2027-2032)
Figure 82. Global Oncology Radiopharmaceutical Sales Market Share Forecast by Type (2027-2032)
Figure 83. Global Oncology Radiopharmaceutical Revenue Market Share Forecast by Type (2027-2032)
Figure 84. Global Oncology Radiopharmaceutical Sales Market Share Forecast by Application (2027-2032)
Figure 85. Global Oncology Radiopharmaceutical Revenue Market Share Forecast by Application (2027-2032)
